# Gene Therapy for X-linked Chronic Granulomatous Disease

> **NCT02757911** · PHASE1,PHASE2 · TERMINATED · sponsor: **Genethon** · enrollment: 3 (actual)

## Conditions studied

- X-Linked Chronic Granulomatous Disease

## Interventions

- **GENETIC:** X vivo gene therapy

## Key facts

- **NCT ID:** NCT02757911
- **Lead sponsor:** Genethon
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06-24
- **Primary completion:** 2019-09-16
- **Final completion:** 2025-10-17
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Las patient early withdrawed from the study
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02757911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02757911, "Gene Therapy for X-linked Chronic Granulomatous Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02757911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*